Pharma Reviews: US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil

Mumbai: Regulatory scrutiny of the US Food and Drug Administration (FDA) for domestic pharmaceutical facilities is expected to remain intense over ...
Read more: US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil